跳至主要内容
临床试验/JPRN-UMIN000002554
JPRN-UMIN000002554已完成未知

Evaluation of selective COX-2 inhibitor for the protection of intestinal mucosal damage in comparison to NSAID in patients with rheumatoid arthritis (Investigation by capsule endoscopy and measurement of biomarkers for rheumatoid arthritis) - Evaluation of selective COX-2 inhibitor for the protection of intestinal mucosal damage in comparison to NSAID in rheumatoid arthritis

Osaka University0 个研究点目标入组 30 人开始时间: 2009年9月28日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients treated with biologics (anti-TNF antibody, anti-IL-6R antibody, etc) 2.Patients treated with corticosteroid(>10mg of prednisolone) 3.Patients treated with aspirin. 4.Patients treated with anti-ulcer drugs (misoprostol,teprenone,rebamipide,etc) 5. Patients with active peptic ulcer in stomach or duodenum

研究者

相似试验

Evaluation of selective COX-2 inhibitor for the... | 临床试验